TNF and rheumatoid arthritis: Etanercept (Enbrel) is a recombinant dimer of human soluble TNFRII linked by the constant Fc portion of human immunoglobulin 1 (IgG1) and was the first anti-TNF drug to be approved for the treatment of rheumatoid arthritis by the US Food and Drug Administration.